Holen Sie sich die Stockscreener-App
60.74
2.29%
1.36
Schlusskurs vom Vortag:
$59.38
Offen:
$59.13
24-Stunden-Volumen:
300.27K
Relative Volume:
0.79
Marktkapitalisierung:
$2.10B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-16.55
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
+7.94%
1M Leistung:
+17.69%
6M Leistung:
+3.83%
1J Leistung:
+32.16%
1-Tages-Spanne:
$58.56
$60.83
1-Wochen-Bereich:
$55.99
$62.00
52-Wochen-Spanne:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
60.74 | 1.95B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
What analysts say about Disc Medicine Inc. stockUnrivaled growth potential - Autocar Professional
Disc Medicine’s Strategic Advancements and Regulatory Progress Drive Buy Rating - TipRanks
Disc Medicine Inc. Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com
What drives Disc Medicine Inc. stock priceHigh-return market picks - jammulinksnews.com
Disc Medicine To Seek FDA Approval For Bitopertin In EPP, A Painful Sunlight Sensitivity Disorder - Nasdaq
Disc Medicine’s (IRON) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Disc Medicine's NDA Submission for Bitopertin in EPP: A Catalyst-Driven Opportunity in a High-Unmet-Need Market - AInvest
Disc Medicine to submit NDA for bitopertin in EPP in October - Investing.com India
Truist Securities initiates Disc Medicine stock with Buy rating, $86 target - Investing.com Canada
Disc Medicine, Inc. Receives Positive FDA Feedback for Bitopertin NDA Submission in Erythropoietic Protoporphyria - Nasdaq
Disc Medicine Announces Positive Pre-NDA Meeting and - GlobeNewswire
Is Disc Medicine Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
why disc medicine inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛
Disc Medicine(IRON) Soars 7.28% on Insider Trading, Analyst Rating - AInvest
Disc medicine CFO Franchi sells $119k in shares - Investing.com
Disc medicine CFO Franchi sells $119k in shares By Investing.com - Investing.com South Africa
Raymond James reiterates Strong Buy on Disc Medicine stock amid Bristol Myers trial results - Investing.com Canada
Why Disc Medicine Inc. stock attracts strong analyst attentionMarket Ready Callouts - Newser
How Disc Medicine Inc. stock performs during market volatilityCapital Safe Stock Watchlist - Newser
What makes Disc Medicine Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Disc Medicine Elects Nadim Ahmed as Director - The Globe and Mail
Disc Medicine appoints Nadim Ahmed to board of directors By Investing.com - Investing.com South Africa
Disc medicine CFO Franchi sells $115k in stock By Investing.com - Investing.com Canada
Disc medicine CFO Franchi sells $115k in stock - Investing.com
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $1,925,484.00 in Stock - Defense World
Disc Medicine Appoints Nadim Ahmed To Board - citybiz
Disc Medicine appoints Nadim Ahmed to board of directors - Investing.com
Disc Medicine, Inc. Appoints Nadim Ahmed to Board of Directors - Nasdaq
Disc Medicine Appoints Nadim Ahmed to its Board of Directors - The Manila Times
Disc Medicine Strengthens Board with Ex-BMS President as Bitopertin NDA Filing Approaches - Stock Titan
Amalgamated Bank Purchases 219 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT - MSN
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Franchi Jean M. | Chief Financial Officer |
Jul 17 '25 |
Sale |
59.00 |
2,031 |
119,829 |
63,499 |
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):